Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
出版年份 2022 全文链接
标题
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
作者
关键词
-
出版物
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
Volume Volume 15, Issue -, Pages 1845-1864
出版商
Informa UK Limited
发表日期
2022-06-16
DOI
10.2147/dmso.s369712
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma
- (2022) Sohji Nishina et al. Cancers
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
- (2021) Sachiko Hattori et al. Diabetology & Metabolic Syndrome
- Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus
- (2021) Jaquellyne Gurgel Penaforte-Saboia et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology
- (2021) Emi Kawakita et al. Cancers
- The role of incretins and incretin-based drugs in autoimmune diseases
- (2021) Shabnam Radbakhsh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan
- (2021) Wei-Hao Hsu et al. Frontiers in Public Health
- Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
- (2021) Anand-Krishna Singh et al. Pharmaceuticals
- Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway
- (2021) Xin Wang et al. Cell Death Discovery
- Cellular expression of CD26/dipeptidyl peptidase IV
- (2021) Toshihiko IWANAGA et al. BIOMEDICAL RESEARCH-TOKYO
- The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
- (2021) Tianli Zhang et al. Frontiers in Pharmacology
- Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions
- (2020) Shiying Shao et al. PHARMACOLOGY & THERAPEUTICS
- Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects
- (2020) Mitsuhiro Kawakubo et al. Scientific Reports
- Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
- (2020) Jiahua Li et al. Clinical Journal of the American Society of Nephrology
- Could SCGF-Beta Levels Be Associated with Inflammation Markers and Insulin Resistance in Male Patients Suffering from Obesity-Related NAFLD?
- (2020) Giovanni Tarantino et al. Diagnostics
- Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
- (2020) Alexandros Sachinidis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin mitigates DPP-4 inhibitor-induced breast cancer metastasis via suppression of mTOR signaling
- (2020) Emi Kawakita et al. MOLECULAR CANCER RESEARCH
- Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases
- (2020) Ramona Nicotera et al. PHARMACOLOGICAL RESEARCH
- Soluble Dipeptidyl Peptidase-4 Induces Fibroblast Activation Through Proteinase-Activated Receptor-2
- (2020) Shih-Yi Lee et al. Frontiers in Pharmacology
- Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease
- (2020) Ilaria Barchetta et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
- (2019) Carolyn F. Deacon Frontiers in Endocrinology
- DPP-4 inhibition: А novel therapeutic approach to the treatment of pulmonary hypertension?
- (2019) Marko Anderluh et al. PHARMACOLOGY & THERAPEUTICS
- The incretin system in healthy humans: The role of GIP and GLP-1
- (2019) Jens Juul Holst METABOLISM-CLINICAL AND EXPERIMENTAL
- Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
- (2019) Teresa Salvatore et al. Nutrients
- The Origin and Understanding of the Incretin Concept
- (2018) Jens F. Rehfeld Frontiers in Endocrinology
- Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4
- (2018) A. Casrouge et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option
- (2017) Gauri Dhir et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
- (2017) Christian Baumeier et al. Molecular Metabolism
- Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
- (2017) Ming Zhao et al. Scientific Reports
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
- (2016) Shahinul Alam et al. Saudi Journal of Gastroenterology
- The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
- (2016) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
- (2016) Bo Ahren Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance
- (2015) K. Kaku et al. DIABETES OBESITY & METABOLISM
- Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice
- (2015) Tetsuya Sujishi et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- DPP4 in diabetes
- (2015) Diana Röhrborn Frontiers in Immunology
- Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
- (2014) Angelo Avogaro et al. CURRENT PHARMACEUTICAL DESIGN
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- The pharmacokinetic considerations and adverse effects of DDP-4 inhibitors
- (2014) Theodosios D Filippatos et al. Expert Opinion on Drug Metabolism & Toxicology
- Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types
- (2013) X. Ou et al. BLOOD
- The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin
- (2013) Hidetaka Hamasaki et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Global control of hepatitis C: where challenge meets opportunity
- (2013) David L Thomas NATURE MEDICINE
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl peptidase-4: A key player in chronic liver disease
- (2013) Minoru Itou WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of insulin resistance in obesity
- (2013) Jianping Ye Frontiers of Medicine
- Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
- (2013) Baptist Gallwitz Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
- (2013) Miyako Kishimoto Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
- (2012) James L. Trevaskis et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
- (2012) Yoshio Sumida et al. BMC GASTROENTEROLOGY
- CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma
- (2012) Keisuke Aoe et al. CLINICAL CANCER RESEARCH
- Sitagliptin-Associated Angioedema
- (2012) A. R. Gosmanov et al. DIABETES CARE
- Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasis
- (2012) Ambak K. Rai et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The role of tumor cells in the modification of T lymphocytes activity — the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I
- (2012) Katarzyna Starska et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines
- (2012) CLAIRE H. WILSON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area
- (2012) Ichiro Miyajima et al. JOURNAL OF GASTROENTEROLOGY
- Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens
- (2012) Masahiro Sakata et al. JOURNAL OF GASTROENTEROLOGY
- Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
- (2012) Yuichiro Eguchi et al. JOURNAL OF GASTROENTEROLOGY
- Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray
- (2012) Wassim Rahman et al. LIVER INTERNATIONAL
- Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis
- (2012) Hal E Broxmeyer et al. NATURE MEDICINE
- Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice
- (2012) Hannelouise Kissow et al. REGULATORY PEPTIDES
- The Phenotypic Characteristic of Liver-Derived Stem Cells From Adult Human Deceased Donor Liver
- (2012) J.-H. Lee et al. TRANSPLANTATION PROCEEDINGS
- Touch of Chemokines
- (2012) Xavier Blanchet et al. Frontiers in Immunology
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
- (2011) J. Shirakawa et al. DIABETES
- CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation
- (2011) W. Jungraithmayr et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus
- (2011) Yasuji Arase et al. HEPATOLOGY RESEARCH
- Use of HOMA-IR in hepatitis C
- (2011) M. Eslam et al. JOURNAL OF VIRAL HEPATITIS
- Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
- (2011) Gianluca Svegliati-Baroni et al. LIVER INTERNATIONAL
- Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism
- (2011) Masayuki Miyazaki Molecular Medicine Reports
- Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspective
- (2011) Carolin Lackner Expert Review of Gastroenterology & Hepatology
- Insulin-sensitive obesity
- (2010) Nora Klöting et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Sitagliptin-Associated Drug Allergy: Review of Spontaneous Adverse Event Reports
- (2010) Shrey Desai ARCHIVES OF INTERNAL MEDICINE
- Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats
- (2010) Bárbara Maiztegui et al. CLINICAL SCIENCE
- Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial
- (2010) Y. Iwamoto et al. DIABETES OBESITY & METABOLISM
- Inhibition of multifunctional dipeptidyl peptidase-IV: Is there a risk of oncological and immunological adverse effects?
- (2010) Tomas Stulc et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor
- (2010) Lei Tian et al. ENDOCRINOLOGY
- The dipeptidyl peptidase IV family in cancer and cell biology
- (2010) Denise M. T. Yu et al. FEBS Journal
- Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
- (2010) Nobuyoshi Fukushima et al. HEPATOLOGY RESEARCH
- Chemokine antagonism in chronic hepatitis C virus infection
- (2010) Edgar D. Charles et al. JOURNAL OF CLINICAL INVESTIGATION
- Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
- (2010) Armanda Casrouge et al. JOURNAL OF CLINICAL INVESTIGATION
- A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
- (2010) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Hepatocellular ballooning in NASH
- (2010) Stephen Caldwell et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
- (2010) Shani Ben-Shlomo et al. JOURNAL OF HEPATOLOGY
- Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker
- (2010) Gábor Firneisz et al. PLoS One
- Alogliptin: a new addition to the class of DPP-4 inhibitors
- (2010) Marc Rendell Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- On the origin of serum CD26 and its altered concentration in cancer patients
- (2009) Oscar J. Cordero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intrathecally injected Ile-Pro-Ile, an inhibitor of membrane ectoenzyme dipeptidyl peptidase IV, is antihyperalgesic in rats by switching the enzyme from hydrolase to synthase functional mode to generate endomorphin 2
- (2009) Kornél Király et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by Diprotin A
- (2009) Brandon K. Wyss et al. EXPERIMENTAL HEMATOLOGY
- Decreased Expression of T Lymphocyte Co-Stimulatory Molecule CD26 on Invariant Natural Killer T Cells in Systemic Lupus Erythematosus
- (2009) P. T. Y. Wong et al. IMMUNOLOGICAL INVESTIGATIONS
- A CD26-Controlled Cell Surface Cascade for Regulation of T Cell Motility and Chemokine Signals
- (2009) Z. Liu et al. JOURNAL OF IMMUNOLOGY
- Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals after the Initiation of HBV‐Active Antiretroviral Therapy
- (2009) Megan Crane et al. JOURNAL OF INFECTIOUS DISEASES
- Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats
- (2008) Xiaowen Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- (2008) W. Kim et al. PHARMACOLOGICAL REVIEWS
- CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
- (2007) Timothy et al. Frontiers in Bioscience-Landmark
- Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema
- (2007) James Brian Byrd et al. HYPERTENSION
- Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance
- (2007) Minoru Itou et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started